Approved for MDD in 2018, iTBS is a quicker form of repetitive transcranial magnetic stimulation (rTMS), with sessions averaging 3 minutes as compared with 40 minutes for traditional rTMS sessions -- ...

The results also highlight the fact that one shot may still be better than none. Having at least one dose prevented an ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers.

In a small phase II trial, radiation-free treatment with pembrolizumab (Keytruda) and platinum-based chemotherapy alone ...

In the study, cystatin-C based eGFR estimated glomerular filtration rate (eGFR) went from a baseline around 88 ml/min/1.73 m ...

Among nearly 1,500 young adults, the weighted prevalence of using cannabis and/or alcohol to get to sleep was 22.4%, with ...

Regular Medicare, which most people qualify for after turning 65, does not come with prescription coverage, known as Part D.

Abcejo's general message to upper management is that remimazolam has value because it is hemodynamically more stable than propofol, results in better quality of recovery, and gives better procedural ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

At World Sleep 2025, a full-day course spotlighted artificial intelligence (AI)'s promise -- and its limits -- in sleep ...

It is unclear exactly what percentage of the individuals who were initially slated for termination have now had their fates ...

Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...